Joshua McGee

Keylicon Biosciences

BIOGRAPHY

Dr. Joshua McGee is the Chief Scientific Officer and the Co-Founder of Keylicon Biosciences, where he leads the development of a first-in-class modified self-amplifying RNA technology. His work builds on a strong foundation in biomedical engineering and innovative approaches to RNA platforms, vaccines, and therapeutics.

Joshua has advanced research in self-amplifying RNA optimisation, lipid nanoparticle engineering, and novel vaccine design. He is an inventor on more than ten patent applications and has published his work in leading journals, including Nature Biotechnology.